Pharmacokinetics of an Increased Atazanavir Dose with and without Tenofovir During the Third Trimester of Pregnancy

BACKGROUND: Reduced atazanavir exposure has been demonstrated during pregnancy with standard atazanavir/ritonavir dosing. We studied an increased dose during the third trimester of pregnancy. METHODS: IMPAACT 1026s is a prospective, non-blinded pharmacokinetic study of HIV-infected pregnant women ta...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Kreitchmann, Regis, Best, Brookie M., Wang, Jiajia, Stek, Alice, Caparelli, Edmund, Watts, D. Heather, Smith, Elizabeth, Shapiro, David E., Rossi, Steve, Burchett, Sandra K., Hawkins, Elizabeth, Byroads, Mark, Cressey, Tim R., Mirochnick, Mark
Format: Artigo
Język:Inglês
Wydane: 2013
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3625451/
https://ncbi.nlm.nih.gov/pubmed/23392467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e318289b4d2
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy